Assa Oumie

Comparing mutation calls in fixed tumour samples between the affymetrix OncoScan® array and PCR based next-generation sequencing

P. Quirke, F. Brew, H. Wood, 2017, BMC Medical Genomics.

Cross-laboratory validation of the OncoScan® FFPE Assay, a multiplex tool for whole genome tumour profiling

Phil Quirke, Fiona Brew, Joseph M Foster, 2015, BMC Medical Genomics.

Genomic complexity of urothelial bladder cancer revealed in urinary cfDNA

Fabiana Ramos Vasques, M. Zeegers, N. James, 2016, European Journal of Human Genetics.

HER2 overexpression and amplification as a potential therapeutic target in colorectal cancer: analysis of 3256 patients enrolled in the QUASAR, FOCUS and PICCOLO colorectal cancer trials

J. Barrett, D. Kerr, R. Gray, 2016, The Journal of pathology.

Comparing mutation calls in fixed tumour samples between the affymetrix OncoScan® array and PCR based next-generation sequencing

P. Quirke, F. Brew, H. Wood, 2017, BMC Medical Genomics.